Ronis M J, Aronson J, Gao G G, Hogue W, Skinner R A, Badger T M, Lumpkin C K
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Toxicol Sci. 2001 Aug;62(2):321-9. doi: 10.1093/toxsci/62.2.321.
To identify possible direct and indirect mechanisms underlying the effects of lead on skeletal growth, 3 studies were conducted. In the first study, 1 male and 1 female pup/litter (n = 5 litters), were exposed ad libitum to 0, 825, or 2475 ppm lead acetate in the drinking water from gestational day 4 to euthanasia on day 55. Tibial strength was tested by 3-point bending and plasma levels of vitamin D metabolites were measured. A dose-dependent decrease of the load to failure was demonstrated but only in male pups. No differences in plasma levels of vitamin D metabolites were observed. In the second study, conducted to test if hormone treatment would attenuate the lead deficits, male and female pups were exposed to 0 or 2475 ppm lead acetate and then, from 30-60 days of age, received either saline vehicle, L-dopa, testosterone (males only), dihydrotestosterone (DHT, males only), or estradiol (females only). Lead exposure significantly reduced somatic growth, longitudinal bone growth, and bone strength during the pubertal period. Sex steroid replacement did not restore skeletal parameters in lead-exposed rats. L-Dopa increased plasma insulin-like growth factor 1 (IGF(1)) concentrations, rates of bone growth, and bone strength measures in controls while having no effect in lead-exposed pups. The third study was conducted at 100 days of age, when endocrine parameters have been shown to be normalized, to test for effects of lead exposure on bone formation during tibial limb lengthening (distraction osteogenesis, DO). Both DO gap x-ray density and proximal new endosteal bone formation were decreased in the distraction gaps of the lead-treated animals (p < 0.01). In conclusion, lead exposure reduced somatic growth, longitudinal bone growth, and bone strength during the pubertal period, and these effects could not be reversed by a growth hormone (GH) axis stimulator or by sex-appropriate hormones. Finally, lead exposure appears to specifically inhibit osteoblastogenesis in vivo in adult animals.
为确定铅对骨骼生长产生影响的潜在直接和间接机制,开展了3项研究。在第一项研究中,从妊娠第4天至第55天实施安乐死期间,每窝1只雄性和1只雌性幼崽(n = 5窝)随意饮用含0、825或2475 ppm醋酸铅的饮用水。通过三点弯曲测试胫骨强度,并测量血浆中维生素D代谢物水平。结果显示,仅在雄性幼崽中出现了负荷至失效的剂量依赖性降低。未观察到血浆维生素D代谢物水平存在差异。在第二项研究中,为测试激素治疗是否会减轻铅缺乏,雄性和雌性幼崽暴露于0或2475 ppm醋酸铅中,然后在30至60日龄时,分别接受生理盐水载体、左旋多巴、睾酮(仅雄性)、二氢睾酮(DHT,仅雄性)或雌二醇(仅雌性)。铅暴露显著降低了青春期的体细胞生长、纵向骨生长和骨强度。性类固醇替代未能恢复铅暴露大鼠的骨骼参数。左旋多巴增加了对照组血浆胰岛素样生长因子1(IGF(1))浓度、骨生长速率和骨强度指标,而对铅暴露幼崽无影响。第三项研究在100日龄时进行,此时内分泌参数已显示正常,以测试铅暴露对胫骨肢体延长(牵张成骨,DO)期间骨形成的影响。在接受铅治疗动物的牵张间隙中,DO间隙X线密度和近端新骨内膜骨形成均降低(p < 0.01)。总之,铅暴露降低了青春期的体细胞生长、纵向骨生长和骨强度,生长激素(GH)轴刺激剂或合适的性激素无法逆转这些影响。最后,铅暴露似乎在成年动物体内特异性抑制成骨细胞生成。